0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query la merie publishing competitor analysis complement c5 inhibitors 2017 biosuperiors biosimilars.Your search for "" gave back 1504468 results.
The Competitive Intelligence Report Amyloid beta- and Tau-Targeted Antibodies & Vaccines as of September 2015 provides a competitor analysis in...
Catalog:
La Merie Publishing
October 2015
Price: USD 345.00
The Competitive Intelligence report about Interleukin-23 (IL-23) and IL-12/23 antagonists provides a competitor analysis of approved or being...
Catalog:
La Merie Publishing
September 2015
Price: USD 115.00
The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis...
Catalog:
La Merie Publishing
November 2014
Price: USD 381.00
The present Competitive Intelligence Report about peptide therapeutics provides a competitor evaluation in the field of marketed and new molecules...
Catalog:
La Merie Publishing
September 2014
Price: USD 317.00
This Competitive Intelligence report about RORgamma Antagonists and Agonists evaluates the landscape of investigational small molecules targeting the...
Catalog:
La Merie Publishing
October 2019
Price: USD 280.00
Novel Prophylactic and Therapeutic Approaches to Manage and Prevent Clostridium difficile Infections (CDI) Clostridium difficile infections (CDI) are...
Catalog:
La Merie Publishing
January 2014
Price: USD 267.00
Competitor Analysis: CD19-Targeted Therapeutics – 2016 Update This Competitive Intelligence report about CD19-Targeted Therapeutics provides a...
Catalog:
La Merie Publishing
April 2016
Price: USD 350.00
The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development...
Catalog:
La Merie Publishing
November 2014
Price: USD 499.00
Cytokine-engineering as a measure to reduce dose-limiting toxicities of immunocytokines The development of recombinant cytokines, or mainly antibody-...
Catalog:
La Merie Publishing
January 2014
Price: USD 334.13
The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides a competitor analysis in the...
Catalog:
La Merie Publishing
January 2015
Price: USD 249.00
The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor...
Catalog:
La Merie Publishing
November 2014
Price: USD 444.00
According to our Publisher latest study, the global Mitogen-Activated Protein Kinase Inhibitor market size was valued at USD million in 2022 and is...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Myasthenia Gravis - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
November 2019
Price: USD 2,000.00
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases This Competitive Intelligence report about Bispecific...
Catalog:
La Merie Publishing
June 2016
Price: USD 560.00
Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct'...
Catalog:
Global Markets Direct
October 2022
Price: USD 2,500.00
